Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

Clinical Lymphoma & Myeloma
Eva KimbyJ Bladé

Abstract

This report by an international consensus panel updates current recommendations for defining clinical response in Waldenstrom's macroglobulinemia (WM). The previously published response criteria incorporated parameters for monoclonal protein reduction and/or improvement of marrow and nodal involvement, and included definitions of complete and partial remissions. The criteria have been updated to include minor response and stable disease categories. In addition, the criteria now recognize that delayed responses after treatment with nucleoside analogues and biologic agents and the time point for assessing response in patients with WM should be considered so as to not miss or miscategorize a response. The new criteria should therefore help in better delineating responses to therapy in patients with WM, particularly with the wide use of nucleoside analogues and biologically based agents for this disease.

References

Mar 2, 1999·Archives of Pathology & Laboratory Medicine·D F KerenR H Tomar
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meletios A DimopoulosNikolaos Anagnostopoulos
May 16, 2003·The New England Journal of Medicine·Vandana M KrishnaKurt J Bloch
Sep 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S P TreonK C Anderson
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S P TreonUNKNOWN Waldenström's Macroglobulinemia Clinical Trials Group
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meletios A DimopoulosSteven P Treon

❮ Previous
Next ❯

Citations

Jan 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Irene M GhobrialPaul G Richardson
Aug 21, 2008·Blood·Steven P TreonKenneth C Anderson
Jun 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven P TreonIrene M Ghobrial
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irene M GhobrialThomas E Witzig
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irene M GhobrialJeffrey Matous
Nov 12, 2009·Haematologica·Zachary R HunterSteven P Treon
Jun 27, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Giovanni CarulliMario Petrini
Jul 21, 2009·Blood·Steven P Treon
Aug 7, 2012·Leukemia & Lymphoma·Morie Gertz
Jan 21, 2012·Leukemia & Lymphoma·Christopher Parrish, Roger G Owen
Apr 6, 2012·Expert Review of Hematology·Pierre Morel, Giampaolo Merlini
Nov 19, 2010·Expert Review of Hematology·Ramón García-Sanz, Enrique M Ocio
May 19, 2012·Seminars in Oncology·Sheeba K Thomas, Larry W Kwak
Apr 7, 2010·La Revue de médecine interne·S PoulainX Leleu
Apr 14, 2009·Clinical Lymphoma & Myeloma·Abraham M VargheseRoger G Owen
Apr 14, 2009·Clinical Lymphoma & Myeloma·Leukothea IoakimidisSteven P Treon
Mar 20, 2009·La Presse médicale·Noël Milpied
May 24, 2008·Critical Reviews in Oncology/hematology·Umberto VitoloSilvia Montoto
Jun 17, 2008·Cancer Letters·Xavier LeleuIrene M Ghobrial
Aug 4, 2007·British Journal of Haematology·Rafael Fonseca, Suzanne Hayman
Dec 18, 2008·European Journal of Haematology·Xavier LeleuIrene M Ghobrial
Nov 16, 2012·British Journal of Haematology·Roger G OwenUNKNOWN VIth International Workshop on Waldenström macroglobulinaemia
Oct 19, 2011·Journal of the Peripheral Nervous System : JPNS·Berengere GrusonBruno Royer
Jun 18, 2011·American Journal of Hematology·Ranjit BanwaitIrene M Ghobrial
Oct 23, 2012·Clinical Lymphoma, Myeloma & Leukemia·Steven P TreonZachary R Hunter
Apr 2, 2011·Clinical Lymphoma, Myeloma & Leukemia·Steven P TreonPatricia Sheehy
Apr 2, 2011·Clinical Lymphoma, Myeloma & Leukemia·Pierre Morel, Giampaolo Merlini
Mar 16, 2013·Clinical Lymphoma, Myeloma & Leukemia·Alessandra TedeschiEnrica Morra
Apr 8, 2010·Clinical Lymphoma, Myeloma & Leukemia·Meletios A DimopoulosSteven P Treon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M A DimopoulosSteven P Treon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Christine I ChenNational Cancer Institute of Canada Clinical Trials Group
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Steven P TreonAshraf Badros
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Steven P TreonKenneth C Anderson
© 2022 Meta ULC. All rights reserved